About Holista Colltech Ltd

Holista Colltech Ltd ("Holista") is a leading innovator in health and wellness solutions based in Perth, Australia. It is listed on the Australian Securities Exchange (ASX:HCT)

Holista’s core business divisions are Health Supplements, Healthy Food Ingredients, Ovine Collagen and Infection Control Solutions. The suite of health and food related solutions combines the best of nature and science is to address the evolving needs so that people can live better and healthier lives.

Key products include one of the market-leading and best-selling health supplements, low-GI food ingredients used by leading food manufacturers, disease-free and medical grade ovine collagen, all-natural, non-toxic and effective sanitizers for consumers and industrial applications.

Over the years, the company has successfully developed and patented world-leading technologies in the field of Global Health and Wellness Industry and has a vast customer base in Asia, Australia and USA.

Holista is passionate to combine economic success with enriching lives for a sustainable future.

Infection Control Solutions Division

Managing beyond the pandemic with safe solutions for everyone.

Propelled by the Covid-19 outbreak, Holista secured global distribution rights from US-based Global Infection Control Consultants LLC (GICC) to distribute an active ingredient known as Path-Away® 

Path-Away® is the active ingredient in Holista’s NatShield which is an efficacious all-natural and alcohol-free hand sanitiser, and independently proven to be effective against a range of pathogens, including SARS-CoV-2 (the virus that causes Covid-19).

Holista is close to launching a nasal sanitizing balm containing Protectene, which shares the same properties as Path-Away® which protects the nasal passage from various pathogens including Covid-19.

Product composition consists of all natural and plant-based ingredients, leaving no side effects and suitable for all age groups including expectant and nursing mothers

Holista has partnered with GICC to pursue opportunities for the M3® system outside the US. The system works by dispensing Path-Away® through heating, ventilation and air-conditioning (HVAC) systems to treat airborne viruses.



“On January 2021, Holista started a new division that focused on medical device for infection control. A Joint-venture partnership with Amegajaya Healthcare, CALMS Technologies to provide Covid-19 related services such as “Testing & Tracing” programme to offer to business owners, institutions, and government-linked companies.

We are also partnering with Dr.Carmelo Ferlito, CEO of Centre of Market Education (CME) for research purposes on mass testing strategies and pandemic control.”

Malaysia – Global Strategic Hub

Well-Positioned For Exponential Growth

Diverse growth avenues with strong revenue streams

Global customers with solid products and vast sales network

Market intelligence to address growing markets in health/wellness

Progressive funds providing solid foundation for growth

Proven ability and track record to deliver value

About GeneSign

GeneSign Biotech Co., Ltd

Unit 03, 8th Floor, Building B14, Xiamen Biomedical Industrial Park, 2076 Wengjiao West Road, Haicang District, Xiamen.

A professional manufacturer of in vitro diagnostic reagents, the company was established in 2019 with a registered capital of 5 million. Its business scope mainly includes biotechnology research and development, manufacturing and sales of biological products and materials, biological materials polymerization technology research and development, engineering and technology research and experimental development, technical services and development, technology transfer and promotion as well as first class medical device sales. License items include import and export agency; technology import and export; goods import and export.

The company has a high-quality R&D team through cooperation with professional scientific research institutions locally and abroad. The level of applied technology has steadily risen in the industry rankings, and has achieved many important technological breakthroughs.

When the novel coronavirus (2019-nCoV, or COVID-19) epidemic first broke out in 2020 and facing an unprecedented global epidemic, GeneSign Biotech Co., Ltd developed the coronavirus antigens, antibodies, isothermal nucleic acids, and rapid P CR detection reagents with well known domestic universities and research institutes, achieving breakthroughs progress and obtained CE. During the development process, the company adheres to standardized management with continuous improvement, passed and obtained the 13485 certifications. With excellent product quality, good product performance, leading technical advantages, GeneSign has established long term good partnership with customers locally and large-scale manufacturers abroad.

About Hecin

Guangdong Hecin Scientific, Inc.

4F Building B 4F Building A 1 Ruifa Road Huangpu District Guangzhou, 510700 China

Guangdong Hecin Scientific, Inc. was established in April 2015, focusing on research and development of IVD products on respiratory viruses. The company is in the Hi-Tech incubator Huangpu Hi-Tech Developing zone of Guangzhou. The incubator is based on the National Key Laboratory of Respiratory Diseases led by Zhong Nanshan, who is the member of Chinese Academy of Engineering and leading scientist in the field of respiratory diseases.

Hecin Scientific owns a 5,000 m2 GMP factory and facilities for innovation by highly trained personnel to create and produce new IVD products. Hecin Scientific is also a state-owned enterprise and was supplying test kits to the Chinese military. Currently, Hecin has more than 160 full time employees working in the company and is expanding rapidly.

Country Representative

Korina Bejarano – US  

Powerkor Global LLC 
1960 Oxford Ave, Cardiff, CA 92007, USA.

Michael Ladd – Canada 

1640 California Ave 
Ontario K6V5V5 Canada 

Steve Tollman – United Kingdom 

Vital Group UK  
Unit 16, The I.O. Centre,  Hearle Way, Hatfield Business Park, Hertfordshire, United Kingdom. 
AL10 9EW

Baruch Vega – South America 

ITS-Integrated TecMed Solutions LLC. 
Director Latin American Operations 

Mr. Alvaro Jose Marquez – Colombia  

Annar Health Technologies  
Av. Américas #39 -79 
Bogotá Colombia 

United Pharmaceutical  – Thailand  

Chiang Mai Head Office  
United Pharmaceutical Co., Ltd,  
165/1 Village, No.3 Wieng Sub-district, Fang District, Chiang Mai Province, Thailand 50110 

Dr Swanand- India 

C-703, Vidya, Sankalp Sachnivas CHS, NNP, Goregaon East, Mumbai – 400 097  Maharashtra, India 

Lai Kwok Kin– Singapore 

1 Raffles Place
#02-01 One Raffles Place Mall,
Suite 332, Singapore 048616

Bamboo Earth Sdn Bhd– Malaysia
Mailing Address:
No 13A-2A Ukay Boulevard,
Jalan Lingkaran Tengah Dua,
Hulu Kelang, 68000 Ampang


Business Intent

Value Creation

HOLISTA aims to drive long-term business value creation through responsible investments and innovations.

Social Impact

HOLISTA aims to create progressive alliances with the communities by adding value and socio-economic development to employees, partners and society .

Safeguard Environment

HOLISTA strives to collaboratively reduce environmental impact by responsibly sourcing for sustainable products from animals and plants primarily focused on the wellbeing of people.

Responsible Governance

HOLISTA aims to safeguard the company’s commitment towards integrity by upholding strong governance mechanism and ethical business practices.